Literature DB >> 7866361

The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity.

J Mauskopf1, R Austin, L Dix, R Berzon.   

Abstract

The main symptoms of zoster, a disease caused by the reactivation of the varicella zoster virus (that causes chicken-pox) are: rash, associated with pain, burning, or itching, and pain that outlasts the rash sometimes by months or years. The uncomfortable and long-lasting symptoms of herpes zoster are likely to compromise the patient's quality of life. However, the impact of zoster on health-related quality of life has not previously been measured directly. Recent papers have demonstrated the ability of generic measures to discriminate among patients with different clinical symptoms. In this paper, we demonstrate the convergent validity for zoster of a generic measure, the Nottingham Health Profile (NHP), by measuring its correlation with rash progression, pain levels, and pain medications. The discriminant validity of the NHP was demonstrated by its ability to distinguish between different levels of pain severity. The NHP dimensions most highly correlated with the pain measures, were pain (0.42-0.50), energy (0.34-0.38) and sleep (0.32-0.38). The NHP scores in all six dimensions show large differences at different levels of pain severity that are statistically significant. These results demonstrate the NHP's validity as a measure of health-related quality of life in zoster patients.

Entities:  

Mesh:

Year:  1994        PMID: 7866361     DOI: 10.1007/bf00435395

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  5 in total

Review 1.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

2.  The QLDS: a scale for the measurement of quality of life in depression.

Authors:  S M Hunt; S P McKenna
Journal:  Health Policy       Date:  1992-10       Impact factor: 2.980

3.  Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients.

Authors:  G R Parkerson; R T Connis; W E Broadhead; D L Patrick; T R Taylor; C K Tse
Journal:  Med Care       Date:  1993-07       Impact factor: 2.983

4.  Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations.

Authors:  R H Gracely; R Dubner; P A McGrath
Journal:  Science       Date:  1979-03-23       Impact factor: 47.728

5.  Relationship between functional status and health-related quality-of-life after myocardial infarction.

Authors:  B J O'Brien; M J Buxton; D L Patterson
Journal:  Med Care       Date:  1993-10       Impact factor: 2.983

  5 in total
  13 in total

Review 1.  Evaluation of quality of life for diverse patient populations.

Authors:  K R Yabroff; B P Linas; K Schulman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  The Nottingham Health Profile: score distribution, internal consistency and validity in asthma and COPD patients.

Authors:  M P Jans; F G Schellevis; J T van Eijk
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

3.  The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic.

Authors:  Alexandra Garven; Shauna Brady; Susan Wood; Melinda Hatfield; Jennifer Bestard; Lawrence Korngut; Cory Toth
Journal:  Pain Res Manag       Date:  2011 May-Jun       Impact factor: 3.037

4.  Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patient-reported outcomes survey.

Authors:  Thomas Weinke; Alexander Edte; Sonja Schmitt; Kati Lukas
Journal:  Z Gesundh Wiss       Date:  2010-03-21

5.  The role of stress in the development of herpes zoster and postherpetic neuralgia.

Authors:  J M Livengood
Journal:  Curr Rev Pain       Date:  2000

Review 6.  Reward, motivation, and emotion of pain and its relief.

Authors:  Frank Porreca; Edita Navratilova
Journal:  Pain       Date:  2017-04       Impact factor: 7.926

7.  The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.

Authors:  Robert W Johnson; Didier Bouhassira; George Kassianos; Alain Leplège; Kenneth E Schmader; Thomas Weinke
Journal:  BMC Med       Date:  2010-06-21       Impact factor: 8.775

8.  An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy.

Authors:  William Eardley; Cory Toth
Journal:  J Pain Res       Date:  2010-04-01       Impact factor: 3.133

9.  The importance of catastrophizing for successful pharmacological treatment of peripheral neuropathic pain.

Authors:  Cory Toth; Shauna Brady; Melinda Hatfield
Journal:  J Pain Res       Date:  2014-06-24       Impact factor: 3.133

10.  Hedonic and motivational responses to food reward are unchanged in rats with neuropathic pain.

Authors:  Alec Okun; David L McKinzie; Jeffrey M Witkin; Bethany Remeniuk; Omar Husein; Scott D Gleason; Janice Oyarzo; Edita Navratilova; Brian McElroy; Stephen Cowen; Jeffrey D Kennedy; Frank Porreca
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.